The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A cost-effectiveness analysis of palbociclib plus letrozole as first-line treatment for estrogen receptor-positive, HER2-negative, metastatic breast cancer.
 
Klazien Matter-Walstra
No Relationships to Disclose
 
Matthias Schwenkglenks
No Relationships to Disclose
 
Peter Brauchli
No Relationships to Disclose
 
Dirk Klingbiel
No Relationships to Disclose
 
Konstantin J. Dedes
No Relationships to Disclose